Product Catalogue

View a listing of all Teva products.

Filters

Alphabet

Toggle

Product TA

Toggle

Molecule

Toggle

All Results

No results found

Please change the filter settings to find the product(s) you are looking for. You can also use the search function to look up a product.

A Study to Assess New Formulations of TEV-56286

brain-icon.png
Product TA:
Healthy Participants
View product The primary objective of the study is to assess the relative bioavailability of TEV-56286 test formulations compared to TEV-56286 reference product in healthy adult participants. The secondary objective is to evaluate the safety and tolerability of TEV-56286. The planned duration for each participant is approximately 70 days which includes a 45 day screening period.

Effect of a 5-Day Regimen on Peripheral Stem Cell Mobilization

disease-icon.png
Product TA:
Healthy Participants
View product Please refer to ClinicalTrials.gov for a description of the trial

Mass Balance Clinical Trial With TEV-56286

brain-icon.png
Product TA:
Healthy Participants
View product Primary objectives: To investigate the mass balance and excretion of TEV-56286 following a single oral dose of [14C]-TEV-56286 To assess the pharmacokinetics following a single oral dose of [14C]-TEV-56286 Secondary objective: To evaluate the safety and tolerability of TEV-56286 following once daily multiple oral dose administration The total duration of the clinical trial for each participant is expected to be approximately 59 days.